July 7, 2020 / 2:09 PM / a month ago

BRIEF-HHS, DoD Partner With Regeneron On Large-Scale Manufacturing Of COVID-19 Investigational Therapy

July 7 (Reuters) - U.S. Department of Health and Human Services (HHS):

* HHS, DOD COLLABORATE WITH REGENERON ON LARGE-SCALE MANUFACTURING DEMONSTRATION PROJECT OF COVID-19 INVESTIGATIONAL THERAPEUTIC TREATMENT

* HHS SAYS REGENERON ESTIMATES BETWEEN 70,000 AND 300,000 TREATMENT DOSES COULD BE AVAILABLE FROM PROJECT

* HHS SAYS MANUFACTURING DEMONSTRATION PROJECT WILL TAKE PLACE WHILE CLINICAL TRIALS ARE UNDERWAY

* HHS SAYS DOSES OF MEDICINE WILL BE READY TO SHIP IMMEDIATELY IF CLINICAL TRIALS ARE SUCCESSFUL & FDA GRANTS EUA OR APPROVES MEDICINE Source text: (bit.ly/3iDkHPU)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below